SeerPharma has identified a growing demand from cell and gene therapy manufacturers across the APAC region for expert advisory services and tailored training in Good Manufacturing Practice (GMP). Recognising this need, our team has expanded its capabilities in this specialised area, culminating in the design, development and delivery of a GMP...
Cell therapies are an emerging form of healthcare that have started to produce transformative outcomes for patients with previously refractory diseases, but they are substantially more complex than small molecule or biologic drugs and present significant challenges for researchers and companies in cell therapy translation.
Copyright © SeerPharma
